| Code | CSB-RA007403MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to getagozumab, designed for research targeting endothelin receptor type A (EDNRA). EDNRA is a G protein-coupled receptor that mediates the vasoconstrictive and proliferative effects of endothelin-1, playing crucial roles in vascular tone regulation, smooth muscle cell proliferation, and cellular signaling. Dysregulation of EDNRA signaling is implicated in various pathological conditions including pulmonary arterial hypertension, systemic hypertension, cardiovascular disease, renal disorders, and cancer progression, where it contributes to tumor growth, angiogenesis, and metastasis.
Getagozumab is a humanized monoclonal antibody that specifically binds to EDNRA, blocking endothelin-1-mediated receptor activation. This biosimilar provides researchers with a valuable tool for investigating EDNRA-mediated pathways, studying endothelin system biology, and exploring therapeutic interventions in EDNRA-associated diseases. The recombinant antibody enables mechanistic studies of receptor function, signal transduction pathways, and disease modeling in various experimental systems.
There are currently no reviews for this product.